Medivation Announces Second Quarter 2012 Financial Results Teleconference on August 9, 2012
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 08/02/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss second quarter 2012 financial results and provide a general business update on Thursday, August 9, 2012 at 4:30 p.m. Eastern Time. A press release for the second quarter of 2012 will be released after markets close on August 9, 2012.
Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at .
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.08.2012 - 20:15 Uhr
Sprache: Deutsch
News-ID 171387
Anzahl Zeichen: 1290
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 323 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Announces Second Quarter 2012 Financial Results Teleconference on August 9, 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
